Document is current
Any future updates will be listed below
-
Authors
Bhat, Venkat https://orcid.org/0000-0002-8768-1173
Sengupta, Sarojini M.
Grizenko, Natalie
Joober, Ridha
-
Funding
Funding for this research was provided by:
CANADA-CIHR (MOP#53309)
CANADA-CIHR (MOP# 84537)
CANADA-CIHR (MOP# 126023)
Quebec-FRSQ (FRSQ#6690)
- License Information
-
More Information
Article History
Received: 18 August 2019
Accepted: 27 December 2019
First Online: 21 January 2020
Compliance with ethical standards
:
: The ADHD pharmaco-behavioral study is an ongoing study at the Douglas Mental Health Research Institute in Montreal and has approval from the Douglas Institutional Research Board.
: VB and SMS report no biomedical financial interests or potential conflicts of interest. NG reports receiving research funding from CIHR and is a member of the advisory board for Purdue and Shire. RJ reports having received research funding from CIHR. He is on the advisory boards and speakers’ bureaus of Pfizer, Janssen Ortho, BMS, Sunovion, Otsuka, Lundbeck, Perdue and Myelin. He has received grant funding from them and from AstraZeneca and HLS. He has received honoraria from Janssen Canada, Shire, Lundbeck, Otsuka, Pfizer and from Perdue for CME presentations and royalties for Henry Stewart talks.
